Zacks Investment Management »

Aurinia Pharmaceuticals shares owned by Zacks Investment Management

Quarter-by-quarter ownership of Aurinia Pharmaceuticals (AUPH) shares owned by Zacks Investment Management from 13F filings

Historical chart of Zacks Investment Management investment in Aurinia Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Aurinia Pharmaceuticals held by Zacks Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aurinia Pharmaceuticals by Zacks Investment Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $623k 37k 16.97

More positions owned by Zacks Investment Management

Apple (AAPL)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Caterpillar (CAT)
JPMorgan Chase & Co. (JPM)
Amazon (AMZN)
Wal-Mart Stores (WMT)
Meta Platforms Cl A (META)
Johnson & Johnson (JNJ)
Cisco Systems (CSCO)
Abbvie (ABBV)
Parker-Hannifin Corporation (PH)
Exxon Mobil Corporation (XOM)

View all positions for Zacks Investment Management

Top funds holding Aurinia Pharmaceuticals

Tang Capital Management
BlackRock
Goldman Sachs Group
NEA Management Company
Two Sigma Investments
Arrowstreet Capital, Limited Partnership
State Street Corporation
Morgan Stanley
Marshall Wace
Geode Capital Management
Renaissance Technologies
D. E. Shaw & Co
Vanguard Portfolio Management
Jacobs Levy Equity Management
Caption Management

View all funds holding Aurinia Pharmaceuticals